CYFIP2 activators encompass a group of chemical agents designed to modulate the activity of the CYFIP2 protein, which is an important component involved in actin cytoskeleton dynamics and has been implicated in various cellular functions such as synaptic plasticity, cell morphology, and migration. CYFIP2 interacts with the WAVE regulatory complex (WRC), playing a pivotal role in the regulation of actin polymerization by relaying signals from the Rac1 GTPase to the Arp2/3 complex, which initiates the formation of branched actin networks.
The activation of CYFIP2 can be achieved through either direct or indirect mechanisms. Direct activators might bind to specific domains of CYFIP2, inducing structural changes that enhance its interaction with other components of the WRC or its ability to transmit signals that promote actin polymerization. Such a direct interaction may stabilize the protein or change its conformation in a way that favors its active state. Indirect activators may work through modulating the signaling pathways that impact the function of CYFIP2. These compounds could lead to the upregulation of cytoplasmic signaling molecules that interact with CYFIP2, resulting in enhanced protein activity. They might also influence post-translational modifications of CYFIP2, such as phosphorylation, which could alter its activity or its ability to interact with other proteins in the actin polymerization pathway.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
N-Methyl-D-Aspartic acid (NMDA) | 6384-92-5 | sc-200458 sc-200458A | 50 mg 250 mg | $109.00 $369.00 | 2 | |
NMDA receptor agonist can activate pathways linked to actin dynamics, possibly affecting CYFIP2 and the WAVE complex. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PKC activator that can modulate several cellular processes including actin dynamics, which could influence CYFIP2. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates cAMP levels which can modulate various cellular pathways that might indirectly impact the activity of CYFIP2. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Known to influence Wnt signaling which can intersect with pathways regulating actin dynamics and possibly CYFIP2. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
By inhibiting Rho kinase, it can influence actin cytoskeleton dynamics, potentially affecting CYFIP2's role. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments, which could indirectly influence CYFIP2's role in actin polymerization processes. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Disrupts actin filaments, influencing actin dynamics and possibly CYFIP2's role in these processes. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Inhibits myosin II, affecting actin-myosin interactions which can influence actin dynamics and potentially CYFIP2. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Destabilizes microtubules, which can indirectly influence actin dynamics and proteins like CYFIP2 involved in the process. | ||||||